Clinical Trial Details
EORTC-1410p
Back to Clinical Trials Database
Evaluation of ABT-414 in Children with High Grade Gliomas (Main study: ABT-414 alone or ABT-414 plus temozolomide versus lomustine for recurrent glioblastoma: a randomized phase II study of the EORTC Brain Tumor Group)
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 10-Jan-2017 Date Step1 close: 15-Jan-2019 Date Step2 close: 15-Jan-2019 |
Data management at EORTC | Yes |
Design |
Phase 2 Not randomized / N.A. |
Targeted Sample size | All Groups: 15 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/NCT02343406 |
NCT number | NCT02343406 |
EudraCT | 2014-004438-24 |